Capital Strengthening Following Listing on the Tokyo Stock Exchange Mothers Market
First written in FY2020-Q2. 17 of 19 entries say "Advanced", first in FY2020-Q4. Latest entry: FY2026.
The whole theme swung hardest in 2022: 12 of 45 companies on the "Worse" side.
17 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「1 October 2025–30 June 2026 368,000 137,585,100 4,020 5,789,581 4,020 5,788,581」
During the fiscal year, the exercise of stock acquisition rights increased the number of issued shares by 368,000, and increased stated capital and capital reserves by ¥4.020 million each. - FY2026-H1AdvancedAnnual report
「1 July 2025–30 September 2025 60,000 71,608,550 3,760 5,785,561 3,760 5,722,331 1 October 2025–31 December 2025 104,000 137,321,100 988 5,786,549 988 5,723,319」
The exercise of stock options increased the number of issued shares by a total of 164,000 during the interim consolidated accounting period, and increased stated capital and capital reserves. - FY2025-H1AdvancedAnnual report
「1 July 2024–31 December 2024 32,000 5,777,509 3,752 5,776,509 3,752」
From July to December 2024, the exercise of stock acquisition rights increased the number of issued shares by 32,000, and increased stated capital and capital reserves by ¥3.752 million each. - FY2024-Q1AdvancedAnnual report
「The exercise of share acquisition rights, or stock options, increased capital stock and capital surplus by ¥7.8 million each」
The exercise of stock options increased stated capital and capital reserves by ¥7.8 million each. - FY2023-Q3AdvancedAnnual report
「1 January 2023–31 March 2023」
During the third quarter of the current fiscal year, the exercise of share acquisition rights increased issued shares by 24,000, and increased capital stock and capital surplus by ¥2.556 million each. - FY2023-Q2AdvancedAnnual report
「1 October 2022–31 December 2022 Common shares 120,000 Change in capital stock ¥15.900 million Change in capital surplus ¥15.900 million」
During the second quarter of the current fiscal year, the exercise of share acquisition rights increased common shares by 120,000, and increased capital stock and capital surplus by ¥15.9 million each. - FY2023-Q1AdvancedAnnual report
「The exercise of share acquisition rights attached to convertible bonds with share acquisition rights increased capital stock and capital surplus by ¥2,000 million each, while the exercise of share acquisition rights, or stock options, increased each by ¥8.250 million.」
The exercise of share acquisition rights attached to convertible bonds with share acquisition rights increased shares by 3,073,402, while the exercise of stock options increased shares by 52,000, resulting in increases in capital stock and capital surplus. - FY2022AdvancedAnnual report
「1 October 2021–30 June 2022 Common shares 774,590 Change in capital stock ¥500 million Change in capital surplus ¥500 million」
The conversion of convertible bonds with share acquisition rights resulted in the issuance of 774,590 shares and increased capital stock and capital surplus by ¥500 million each. - FY2022-Q3AdvancedAnnual report
「Between 1 January 2022 and 31 March 2022, issued shares increased by 30,000 through the exercise of share acquisition rights, or stock options, and by 154,918 through the exercise of share acquisition rights attached to convertible bonds with share acquisition rights.」
During the third quarter, the exercise of stock options and convertible bonds with share acquisition rights increased shares by a total of 184,918, and increased capital stock and capital surplus by ¥106.375 million each. - FY2022-Q2AdvancedAnnual report
「1 October 2021–31 December 2021 Common shares 134,000 Change in capital stock ¥32.850 million Change in capital surplus ¥32.825 million」
During the second quarter of the current fiscal year, the exercise of share acquisition rights increased shares by 134,000, and also increased capital stock and capital surplus. - FY2022-Q1AdvancedAnnual report
「Between 1 July 2021 and 30 September 2021, issued shares increased by 39,000 through the exercise of share acquisition rights, or stock options.」
During the first quarter of the current fiscal year, the exercise of stock options increased issued shares by 39,000, and increased capital stock and capital surplus by ¥20.250 million each. - FY2021AdvancedAnnual report
「1 August 2020–30 June 2021 Common shares 208,000 Change in capital stock ¥72.825 million Change in capital surplus ¥72.825 million」
During the current fiscal year, the exercise of share acquisition rights increased common shares by 208,000, and increased capital stock and capital surplus by ¥72.825 million each. - FY2021-Q4AdvancedAnnual report
「Between 1 February 2021 and 30 April 2021, issued shares increased by 103,000 through the exercise of share acquisition rights, or stock options.」
During the current quarter, the exercise of stock options increased issued shares by 103,000, and increased capital stock and capital surplus by ¥47.625 million each. - FY2021-Q3AdvancedAnnual report
「Between 1 November 2020 and 31 January 2021, issued shares increased by 7,000 through the exercise of share acquisition rights, or stock options.」
During the current quarter, the exercise of stock options increased issued shares by 7,000, and increased capital stock and capital surplus by ¥525,000 each. - FY2021-Q2AdvancedAnnual report
「Between 1 August 2020 and 31 October 2020, the total number of issued shares increased by 27,000 shares through the exercise of share acquisition rights, or stock options.」
During the current quarter, the exercise of stock options increased issued shares by 27,000, and increased capital stock and capital surplus by ¥2.025 million each. - FY2020AdvancedAnnual report
「In connection with the listing of the company's common shares on the Tokyo Stock Exchange Mothers market, the over-allotment offering of 367,400 common shares increased capital stock and capital surplus by ¥319.417 million each, while the exercise of share acquisition rights, or stock options, increased each by ¥17.850 million.」
In addition to the capital strengthening associated with the listing, the exercise of stock options increased capital stock and capital surplus by ¥17.850 million each. - FY2020-Q4AdvancedAnnual report
「The over-allotment offering of 367,400 common shares increased capital stock and capital surplus by ¥319.417 million each, and, in connection with the listing of the company's common shares on the Tokyo Stock Exchange Mothers market, the over-allotment offering of 367,400 common shares again increased each by ¥319.417 million. The exercise of share acquisition rights, or stock options, increased capital stock and capital surplus by ¥11.025 million each」
In addition to the capital strengthening associated with the listing, the exercise of stock options increased capital stock and capital surplus by ¥11.025 million each. - FY2020-Q3RestatedAnnual report
「The over-allotment offering of 367,400 common shares increased capital stock and capital surplus by ¥319.417 million each, and the exercise of share acquisition rights, or stock options, increased each by ¥4.875 million」
The capital strengthening associated with the listing was reiterated, and additional capital increases through the exercise of stock options were also reported for the current quarter. - FY2020-Q2First statedAnnual report
「In connection with the listing of the company's common shares on the Tokyo Stock Exchange Mothers market, the company conducted an over-allotment offering of 367,400 common shares, among other measures, resulting in increases of ¥319.417 million each in capital stock and capital surplus」
The third-party allotment associated with the listing increased capital stock and capital surplus by ¥319.417 million each.